HB 1365 — An Act amending Title 35 (Health and Safety) of the Pennsylvania Consolidated Statutes, providing for public health notification programs; and establishing the Medication-Induced Movement Disorders Screening Education Program.

PRINTER'S NO.   1559

                     THE GENERAL ASSEMBLY OF PENNSYLVANIA



                          HOUSE BILL
                          No. 1365
                                                 Session of
                                                   2025

     INTRODUCED BY DELLOSO, APRIL 30, 2025

     REFERRED TO COMMITTEE ON HEALTH, MAY 1, 2025


                                     AN ACT
 1   Amending Title 35 (Health and Safety) of the Pennsylvania
 2      Consolidated Statutes, providing for public health
 3      notification programs; and establishing the Medication-
 4      Induced Movement Disorders Screening Education Program.
 5      The General Assembly of the Commonwealth of Pennsylvania
 6   hereby enacts as follows:
 7      Section 1.     Title 35 of the Pennsylvania Consolidated
 8   Statutes is amended by adding a chapter to read:
 9                                 CHAPTER 56A
10                     PUBLIC HEALTH NOTIFICATION PROGRAMS
11   Subchapter
12      A.   (Reserved)
13      B.   Medication-Induced Movement Disorders Screening Education
14           Program
15                                SUBCHAPTER A
16                                 (Reserved)
17                                SUBCHAPTER B
18                     MEDICATION-INDUCED MOVEMENT DISORDERS
19                          SCREENING EDUCATION PROGRAM
 1   Sec.
 2   56A21.   Definitions.
 3   56A22.   Medication-Induced Movement Disorders Screening
 4                  Education Program.
 5   56A23.   Regulations.
 6   § 56A21.    Definitions.
 7      The following words and phrases when used in this subchapter
 8   shall have the meanings given to them in this section unless the
 9   context clearly indicates otherwise:
10      "Department."     The Department of Health of the Commonwealth.
11      "Medication-induced movement disorders."     A range of
12   neurological conditions characterized by involuntary abnormal
13   movements associated with prolonged use of certain medications
14   that are commonly used for the treatment of mental health
15   conditions.
16      "Program."     The Medication-Induced Movement Disorders
17   Screening Education Program established under section 56A22(a)
18   (relating to Medication-Induced Movement Disorders Screening
19   Education Program).
20   § 56A22.    Medication-Induced Movement Disorders Screening
21                  Education Program.
22      (a)     Establishment.--The Medication-Induced Movement
23   Disorders Screening Education Program is established in the
24   department.
25      (b)     Development.--The department shall develop the program
26   for residents of this Commonwealth in consultation with relevant
27   agencies, including:
28            (1)   The Office of Developmental Programs under the
29      Department of Human Services.
30            (2)   The Office of Mental Health and Substance Abuse

20250HB1365PN1559                        - 2 -
 1      Services under the Department of Human Services.
 2            (3)   The Department of Aging.
 3            (4)   The Department of Drug and Alcohol Programs.
 4            (5)   The Bureau of Community Corrections under the
 5      Department of Corrections.
 6      (c)   Components.--The program must include:
 7            (1)   Educational information on the importance of
 8      screening for and identifying symptoms of medication-induced
 9      movement disorders associated with prolonged use of certain
10      medications that are commonly used for the treatment of
11      mental health conditions.
12            (2)   The development of guidance and educational
13      materials for health care providers on clinical standards and
14      best practices for screening and treating medication-induced
15      movement disorders, including for services provided through
16      telehealth. The guidance shall be:
17                  (i)    Informed by the American Psychiatric Association
18            and other relevant and current professional society
19            practice guidelines.
20                  (ii)   Developed in coordination with relevant health
21            care provider groups.
22            (3)   Education and outreach on the elimination of stigma
23      for individuals living with medication-induced movement
24      disorders related to the treatment of mental health
25      conditions, including medication-induced movement disorder
26      awareness materials for public safety officers.
27      (d)   Electronic informational materials.--The department
28   shall develop electronic informational materials and make
29   available to the public and to health care providers information
30   regarding symptoms of, screenings for and treatment of

20250HB1365PN1559                       - 3 -
 1   medication-induced movement disorders.
 2      (e)     Dissemination of informational materials.--The
 3   department shall:
 4            (1)   Post the informational materials under subsection
 5      (d) on the publicly accessible Internet website of the
 6      department.
 7            (2)   Distribute the guidance and educational information
 8      under subsection (c) to health care providers and facilities
 9      in this Commonwealth serving populations at high risk of
10      medication-induced movement disorders.
11   § 56A23.    Regulations.
12      The department shall promulgate regulations necessary to
13   implement and administer this subchapter.
14      Section 2.     This act shall take effect in 60 days.




20250HB1365PN1559                    - 4 -